Dietary intake of branched-chain amino acids and pancreatic cancer risk in a case-control study from Italy.

Branched-chain amino acids Case-control study Diet Pancreatic cancer Risk factors

Journal

The British journal of nutrition
ISSN: 1475-2662
Titre abrégé: Br J Nutr
Pays: England
ID NLM: 0372547

Informations de publication

Date de publication:
23 Mar 2022
Historique:
entrez: 23 3 2022
pubmed: 24 3 2022
medline: 24 3 2022
Statut: aheadofprint

Résumé

Circulating branched-chain amino acids (BCAAs), a subgroup of the nine essential amino acids, have been associated to pancreatic cancer risk. The aim of this study is to estimate the relation between BCAA intake from diet and pancreatic cancer risk.We analysed data from a multicentric Italian case-control study, including 326 pancreatic cancer cases and 652 controls, matched to cases by study centre, sex and age. A validated food-frequency questionnaire was used to collect the participants' usual diet before cancer diagnosis (or hospital admission for controls) and to compute dietary intakes of various nutrients, including BCAAs. Odds ratios (ORs) and corresponding confidence intervals (CIs) were computed through logistic regression models conditioned on the matching variables and adjusted for major confounding factors, including total energy intake.We found a positive association between the BCAA intake and pancreatic cancer risk (OR for the third quartile=1.88, 95% CI=1.08-3.26; OR for the fourth quartile =2.17, 95% CI=1.17-4.06), with a significant trend in risk. The association persisted after excluding subjects with diabetes and family history of pancreatic cancer, and across strata of selected covariates.These data support and quantify the association between dietary BCAAs and pancreatic cancer, previously suggested by studies on circulating BCAAs.

Identifiants

pubmed: 35317868
pii: S0007114522000939
doi: 10.1017/S0007114522000939
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-19

Auteurs

Marta Rossi (M)

Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Via A. Vanzetti 5, 20133 Milan, Italy.

Federica Turati (F)

Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Via A. Vanzetti 5, 20133 Milan, Italy.
Department of Medicine, Università degli Studi di Udine, 33100 Udine, Italy.

Panagiota Strikoudi (P)

Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Via A. Vanzetti 5, 20133 Milan, Italy.

Monica Ferraroni (M)

Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Via A. Vanzetti 5, 20133 Milan, Italy.

Maria Parpinel (M)

Department of Medicine, Università degli Studi di Udine, 33100 Udine, Italy.

Diego Serraino (D)

Unit of Cancer Epidemiology, Centro di Riferimento Oncologico, National Cancer Institute, IRCCS, Aviano, Italy.

Eva Negri (E)

Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Via A. Vanzetti 5, 20133 Milan, Italy.
Department of Medical and Surgical Sciences, Alma Mater Studiorum - Università di Bologna, 40138 Bologna, Italy.

Carlo La Vecchia (C)

Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Via A. Vanzetti 5, 20133 Milan, Italy.

Classifications MeSH